Valeant to spend $27.5M to upgrade Canadian manufacturing plants

Investments to be made in Manitoba and Quebec.

June 17, 2016   by CP Staff

LAVAL, Que. — Valeant Pharmaceuticals says it will expand its Canadian manufacturing and export capacity by spending a total of $27.5 million on plants in Manitoba and Quebec.

The plant in Steinbach, Man., will receive $15 million by the end of this year.

Valeant will also spend $12.5 million on its plant in Laval, Que., where the company’s headquarters is located.

Its new chairman and CEO said earlier this week that he hopes to revive the battered drug manufacturer following a year of “major distractions.”

Joseph Papa took on the leadership role at Valeant about six weeks ago and told the company’s annual shareholder meeting June 14 that he hopes it will one day once again be ranked among Canada’s most valuable companies.

(Visited 1 times, 1 visits today)

Print this page

Related Stories

Leave a Reply

Your email address will not be published. Required fields are marked *